cn54gp140
Vaccineexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01285141)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cn54gp140
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02589795 | Phase 1 | Nov 1, 2015 | Medical Research Council, University of London |
| NCT01966900 | Phase 1 | Oct 1, 2013 | National Institute for Health Research, United Kingdom, University of London, Wellcome Trust |
| NCT01922284 | Phase 1 | Jun 1, 2013 | Medical Research Council, University of London, Wellcome Trust |
| NCT01285141 | Phase 1 | Jul 1, 2011 | European Union, University of London |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of London | Academic/Hospital | 4 | 4 | 1 | 2011 |
| Medical Research Council | Government | 2 | 0 | 1 | 2013 |
| Wellcome Trust | Academic/Hospital | 2 | 0 | 1 | 2013 |
| European Union | Government | 1 | 0 | 1 | 2011 |
| National Institute for Health Research, United Kingdom | Government | 1 | 0 | 1 | 2013 |
5 organizations
Page 1 / 1